Production (Stage)
Haemonetics Corporation
HAE
$66.06
-$0.10-0.15%
NYSE
| 03/29/2025 | 12/28/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 57.98M | 37.49M | 33.83M | 38.37M | 20.37M |
| Total Depreciation and Amortization | 21.51M | 29.03M | 29.22M | 29.14M | 19.04M |
| Total Amortization of Deferred Charges | 6.70M | -- | -- | -- | 8.60M |
| Total Other Non-Cash Items | -10.63M | 7.78M | 15.61M | -12.35M | 3.48M |
| Change in Net Operating Assets | 40.99M | -30.54M | -29.84M | -82.58M | 12.59M |
| Cash from Operations | 116.56M | 43.77M | 48.82M | -27.42M | 64.08M |
| Capital Expenditure | -15.64M | -1.79M | -11.98M | -9.87M | -6.69M |
| Sale of Property, Plant, and Equipment | 2.45M | 251.00K | 189.00K | 20.36M | 551.00K |
| Cash Acquisitions | 0.00 | 0.00 | -1.76M | -149.15M | 0.00 |
| Divestitures | 43.29M | -- | -- | -- | 1.50M |
| Other Investing Activities | -12.06M | -15.83M | -9.83M | -541.00K | -8.42M |
| Cash from Investing | 18.04M | -17.37M | -23.37M | -139.20M | -13.06M |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 950.00M | 0.00 |
| Total Debt Repaid | -1.56M | 86.64M | 0.00 | -587.76M | -63.50M |
| Issuance of Common Stock | 140.00K | 3.54M | 251.00K | 4.40M | 106.00K |
| Repurchase of Common Stock | -150.00M | -449.00K | -75.04M | -9.75M | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -27.00K | -88.35M | -11.00K | -23.20M | -108.00K |
| Cash from Financing | -151.45M | 1.38M | -74.80M | 333.69M | -63.50M |
| Foreign Exchange rate Adjustments | 2.77M | -6.21M | 4.20M | -1.45M | -2.70M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.08M | 21.56M | -45.15M | 165.63M | -15.18M |